SE0100567D0
(sv)
*
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
WO2003027321A2
(en)
*
|
2001-09-24 |
2003-04-03 |
University Of Aarhus |
Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
|
DK1467761T3
(da)
*
|
2001-11-30 |
2007-02-05 |
Quadra Logic Tech Inc |
Behandling af neovaskulære oftalmiske sygdomme
|
CN1281606C
(zh)
|
2002-03-01 |
2006-10-25 |
安斯泰来制药有限公司 |
含氮杂环化合物
|
WO2004017950A2
(en)
*
|
2002-08-22 |
2004-03-04 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
CA2536930A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Warner-Lambert Company Llc |
Halo substituted benzo`b! thiophenes with pi3k inhibitory activity as therapeutic agents
|
CN1926121B
(zh)
*
|
2004-01-12 |
2012-06-13 |
默克雪兰诺有限公司 |
噻唑衍生物及其应用
|
WO2006018735A2
(en)
*
|
2004-08-18 |
2006-02-23 |
Pharmacia & Upjohn Company Llc |
Triazolopyridine compounds
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
JP2008518954A
(ja)
*
|
2004-10-28 |
2008-06-05 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
ヘッジホッグ経路モジュレーターとしての化合物および組成物
|
US8030327B2
(en)
|
2004-11-08 |
2011-10-04 |
Mds K.K. |
Fused imidazole derivative
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
EP2066676A1
(en)
*
|
2006-09-18 |
2009-06-10 |
Vertex Pharmaceuticals, Inc. |
HETEROCYCLIC INHIBITORS OF c-MET AND USES THEREOF
|
WO2008052733A1
(en)
*
|
2006-10-30 |
2008-05-08 |
Novartis Ag |
Imidazopyridazines as pi3k lipid kinase inhibitors
|
EP1972631A1
(en)
*
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazines as PI3K lipid kinase inhibitors
|
CN101621931A
(zh)
|
2006-11-27 |
2010-01-06 |
H.隆德贝克有限公司 |
杂芳基酰胺衍生物
|
AR064106A1
(es)
*
|
2006-12-05 |
2009-03-11 |
Bayer Schering Pharma Ag |
Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida utiles para el tratamiento de enfermedades y trastornos hiper-proliferativos asociados con la angiogenesis
|
CN101502484B
(zh)
*
|
2006-12-26 |
2011-04-20 |
济南康泉医药科技有限公司 |
同载糖皮质激素和化疗药物的抗癌缓释剂
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
US8536168B2
(en)
|
2007-03-15 |
2013-09-17 |
Novartis Ag |
Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway
|
JP5374492B2
(ja)
|
2007-04-03 |
2013-12-25 |
アレイ バイオファーマ、インコーポレイテッド |
受容体チロシンキナーゼ阻害薬としてのイミダゾ[1,2−a]ピリジン化合物
|
EA200970931A1
(ru)
|
2007-04-10 |
2010-04-30 |
Х. Лундбекк А/С |
Аналоги гетероариламидов
|
CN101687873A
(zh)
*
|
2007-04-17 |
2010-03-31 |
百时美施贵宝公司 |
具有稠合杂环的11β-羟基类固醇Ⅰ型脱氢酶抑制剂
|
CN101754968A
(zh)
*
|
2007-05-09 |
2010-06-23 |
诺瓦提斯公司 |
作为pi3k脂质激酶抑制剂的取代的咪唑并哒嗪
|
KR20100016617A
(ko)
*
|
2007-05-18 |
2010-02-12 |
바이엘 쉐링 파마 악티엔게젤샤프트 |
과증식성 장애 및 혈관형성 관련 질환의 치료에 유용한 저산소증 유도성 인자 (hif)의 억제제
|
CA2695251C
(en)
*
|
2007-08-14 |
2016-06-21 |
Bayer Schering Pharma Aktiengesellschaft |
Fused imidazoles for cancer treatment
|
EP2062893A1
(en)
*
|
2007-10-18 |
2009-05-27 |
Bayer Schering Pharma AG |
Fused imidazoles for cancer treatment
|
ATE516272T1
(de)
|
2007-09-14 |
2011-07-15 |
Ortho Mcneil Janssen Pharm |
1,3-disubstituierte 4-(aryl-x-phenyl)-1h-pyridin- 2-one
|
DE602008004794D1
(de)
|
2007-09-14 |
2011-03-10 |
Addex Pharmaceuticals Sa |
1',3'-disubstituierte 4-phenyl-3,4,5,6-tetrahydro-2h,1'h-ä1,4'übipyridinyl-2'-one
|
EP2060565A1
(en)
|
2007-11-16 |
2009-05-20 |
4Sc Ag |
Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
|
BRPI0819606A2
(pt)
*
|
2007-11-27 |
2017-05-09 |
Cellzome Ltd |
amino triazóis como inobidores de pi3k
|
JP5394404B2
(ja)
|
2008-02-06 |
2014-01-22 |
ブリストル−マイヤーズ スクイブ カンパニー |
キナーゼ阻害剤として有用な置換イミダゾピリダジン類
|
BRPI0908504A2
(pt)
|
2008-02-28 |
2015-08-11 |
Novatis Ag |
Compostos derivados de 3-metil-imidazo[1,2-b]piridazina, uso dos mesmos e composição farmacêutica
|
US8394823B2
(en)
|
2008-04-11 |
2013-03-12 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as DGAT1 inhibitors
|
WO2009126624A1
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolo compounds useful as dgat1 inhibitors
|
EP2303841A1
(en)
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Oxindolyl inhibitor compounds
|
AU2009271019A1
(en)
|
2008-07-14 |
2010-01-21 |
Gilead Sciences, Inc. |
Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases
|
CA2729909A1
(en)
|
2008-07-14 |
2010-01-21 |
Gilead Sciences, Inc. |
Imidazolyl pyrimidine inhibitor compounds
|
WO2010007099A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
WO2010014611A1
(en)
|
2008-07-28 |
2010-02-04 |
Gilead Colorado, Inc. |
Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之三唑吡啶化合物
|
US8895550B2
(en)
|
2008-08-19 |
2014-11-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
US8987251B2
(en)
|
2008-08-19 |
2015-03-24 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
US8557809B2
(en)
|
2008-08-19 |
2013-10-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
BRPI0918055A2
(pt)
|
2008-09-02 |
2015-12-01 |
Addex Pharmaceuticals Sa |
derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato.
|
TWI491610B
(zh)
|
2008-10-09 |
2015-07-11 |
必治妥美雅史谷比公司 |
作為激酶抑制劑之咪唑并嗒腈
|
CN102232074B
(zh)
|
2008-11-28 |
2014-12-03 |
奥梅-杨森制药有限公司 |
作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
|
WO2010074586A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Pathway Therapeutics Limited |
Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives and their use in cancer therapy
|
US8685967B2
(en)
|
2009-04-07 |
2014-04-01 |
Merck Sharp & Dohme Corp. |
Substituted triazolopyridines and analogs thereof
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
DK2430022T3
(da)
|
2009-05-12 |
2013-12-02 |
Janssen Pharmaceuticals Inc |
1,2,4-Triazolo[4,3-a]pyridinderivater og deres anvendelse til behandlingen eller forebyggelse af neurologiske og psykiatriske lidelser
|
ES2409006T3
(es)
|
2009-05-12 |
2013-06-24 |
Janssen Pharmaceuticals Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de los receptores mGluR2
|
WO2010144371A1
(en)
|
2009-06-08 |
2010-12-16 |
Gilead Colorado, Inc. |
Alkanoylamino benzamide aniline hdac inihibitor compounds
|
NZ596783A
(en)
|
2009-06-08 |
2014-01-31 |
Gilead Sciences Inc |
Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
AU2010283806A1
(en)
|
2009-08-12 |
2012-03-01 |
Novartis Ag |
Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
|
WO2011020861A1
(en)
|
2009-08-20 |
2011-02-24 |
Novartis Ag |
Heterocyclic oxime compounds
|
CN106866667B
(zh)
|
2009-11-05 |
2019-11-15 |
圣母大学 |
咪唑并[1,2-a]吡啶类化合物及其合成及使用方法
|
US8741932B2
(en)
*
|
2009-11-06 |
2014-06-03 |
Piramal Enterprises Limited |
Imidazopyridine derivatives
|
DK2519522T3
(en)
*
|
2009-12-30 |
2014-12-08 |
Arqule Inc |
SUBSTITUTED IDAZOPYRIDINYL AMINOPYRIDINE COMPOUNDS
|
US9145419B2
(en)
|
2010-04-28 |
2015-09-29 |
Bristol-Myers Squibb Company |
Imidazopyridazinyl compounds
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
JP5852665B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
ES2552879T3
(es)
|
2010-11-08 |
2015-12-02 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
AU2011328194B2
(en)
|
2010-11-08 |
2015-04-16 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
US20120129872A1
(en)
*
|
2010-11-18 |
2012-05-24 |
Kristi Anne Leonard |
Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
|
CN103649079B
(zh)
|
2010-12-22 |
2016-11-16 |
Abbvie公司 |
丙型肝炎抑制剂及其用途
|
CN102030752A
(zh)
*
|
2011-01-06 |
2011-04-27 |
贵阳中医学院 |
一种制备化合物2-(咪唑并[1,2-a]吡啶-3-基)乙腈的方法
|
US9000186B2
(en)
|
2011-02-01 |
2015-04-07 |
Kyowa Hakko Kirin Co., Ltd. |
Ring-fused heterocyclic derivative
|
ES2563152T3
(es)
|
2011-02-25 |
2016-03-11 |
Array Biopharma Inc. |
Compuestos de triazolopiridina como inhibidores de quinasa PIM
|
WO2012136776A1
(en)
|
2011-04-07 |
2012-10-11 |
Bayer Intellectual Property Gmbh |
Imidazopyridazines as akt kinase inhibitors
|
WO2012156379A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Universität Zürich |
PIK3/P110α INHIBITORS FOR PREVENTION OF RESTENOSIS BY APPLICATION AS AN IMPLANT COATING
|
KR101274986B1
(ko)
*
|
2011-07-27 |
2013-06-17 |
한국과학기술원 |
이미다조피리딘 유도체, 이를 포함하는 PI3K 및/또는 mTOR 저해제용 약학 조성물 및 PI3K 및/또는 mTOR과 연관된 질환 치료용 약학 조성물
|
WO2014021383A1
(ja)
|
2012-07-31 |
2014-02-06 |
協和発酵キリン株式会社 |
縮環複素環化合物
|
US8796305B2
(en)
|
2012-11-05 |
2014-08-05 |
Bayer Pharma Aktiengesellschaft |
Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US9126998B2
(en)
|
2012-11-05 |
2015-09-08 |
Bayer Pharma AG |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US8778964B2
(en)
|
2012-11-05 |
2014-07-15 |
Bayer Pharma Aktiengesellschaft |
Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
|
JP6056872B2
(ja)
*
|
2012-11-30 |
2017-01-11 |
アステラス製薬株式会社 |
イミダゾピリジン化合物
|
WO2014128585A1
(en)
|
2013-02-19 |
2014-08-28 |
Pfizer Inc. |
Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
|
US9776997B2
(en)
|
2013-06-04 |
2017-10-03 |
Bayer Pharma Aktiengesellschaft |
3-aryl-substituted imidazo[1,2-A]pyridines and their use
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
DK3096790T3
(da)
|
2014-01-21 |
2019-10-07 |
Janssen Pharmaceutica Nv |
Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse
|
KR20220039824A
(ko)
|
2014-01-21 |
2022-03-29 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
WO2015123437A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
SI3105218T1
(sl)
|
2014-02-13 |
2019-11-29 |
Incyte Corp |
Ciklopropilamini kot inhibitorji LSD1
|
TWI720451B
(zh)
|
2014-02-13 |
2021-03-01 |
美商英塞特控股公司 |
作為lsd1抑制劑之環丙胺
|
ES2672797T3
(es)
|
2014-02-13 |
2018-06-18 |
Incyte Corporation |
Ciclopropilaminas como inhibidores de LSD1
|
JP2017507140A
(ja)
|
2014-02-19 |
2017-03-16 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
3−(ピリミジン−2−イル)イミダゾ[1,2−a]ピリジン
|
CN106715426A
(zh)
|
2014-03-21 |
2017-05-24 |
拜耳医药股份有限公司 |
氰基取代的咪唑并[1,2‑a]吡啶甲酰胺及其用途
|
CA2938923A1
(en)
*
|
2014-03-24 |
2015-10-01 |
Arqule Inc. |
Process of preparing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine
|
CN106795153B
(zh)
*
|
2014-04-22 |
2020-03-20 |
艾科尔公司 |
取代的咪唑并吡啶基-氨基吡啶化合物的盐和多晶型
|
CN106459037A
(zh)
|
2014-05-02 |
2017-02-22 |
拜耳医药股份有限公司 |
用于治疗心血管疾病的N‑(2‑氨基‑5‑氟‑2‑甲基戊基)‑8‑[(2,6‑二氟苄基)氧基]‑2‑甲基咪唑并[1,2‑a]吡啶‑3‑甲酰胺的对映异构体及其二‑和三氟衍生物的对映异构体
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
WO2016007736A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyrazines as lsd1 inhibitors
|
US9695168B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
|
US10131669B2
(en)
|
2014-07-24 |
2018-11-20 |
Pfizer Inc. |
Pyrazolopyrimidine compounds
|
AP2017009744A0
(en)
|
2014-08-06 |
2017-02-28 |
Pfizer |
Imidazopyridazine compounds
|
WO2016087343A1
(de)
|
2014-12-02 |
2016-06-09 |
Bayer Pharma Aktiengesellschaft |
Heteroaryl-substituierte imidazo[1,2-a]pyridine und ihre verwendung
|
AU2016243939B2
(en)
|
2015-04-03 |
2020-09-03 |
Incyte Holdings Corporation |
Heterocyclic compounds as LSD1 inhibitors
|
PE20181175A1
(es)
|
2015-08-12 |
2018-07-20 |
Incyte Corp |
Sales de un inhibidor de lsd1
|
BR112018005208B1
(pt)
|
2015-09-17 |
2023-12-12 |
Marvin J. Miller |
Compostos heterocíclicos que contêm benzilamina e composições úteis contra infecção micobacteriana
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
CN107304203A
(zh)
*
|
2016-04-20 |
2017-10-31 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
WO2017181973A1
(zh)
*
|
2016-04-20 |
2017-10-26 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
MA44725A
(fr)
|
2016-04-22 |
2019-02-27 |
Incyte Corp |
Formulations d'un inhibiteur de lsd1
|
EP3454852A4
(en)
|
2016-05-11 |
2020-02-26 |
Emory University |
Phosphatidylinositol-3-Kinase Inhibitors
|
WO2018013430A2
(en)
|
2016-07-12 |
2018-01-18 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus infection
|
WO2018184976A1
(de)
|
2017-04-05 |
2018-10-11 |
Bayer Pharma Aktiengesellschaft |
Substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
US20200339567A1
(en)
|
2017-10-24 |
2020-10-29 |
Bayer Aktiengesellschaft |
Substituted imidazopyridine amides and use thereof
|
US10968200B2
(en)
|
2018-08-31 |
2021-04-06 |
Incyte Corporation |
Salts of an LSD1 inhibitor and processes for preparing the same
|
CN113825543A
(zh)
|
2019-03-19 |
2021-12-21 |
勃林格殷格翰动物保健美国公司 |
驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物
|
WO2020216669A1
(de)
|
2019-04-23 |
2020-10-29 |
Bayer Aktiengesellschaft |
Phenylsubstituierte imidazopyridinamide und ihre verwendung
|
WO2021221444A1
(ko)
*
|
2020-04-27 |
2021-11-04 |
주식회사 오토텍바이오 |
Ubr 박스 도메인 리간드로의 화합물
|
MX2022015038A
(es)
|
2020-05-29 |
2023-01-04 |
Boehringer Ingelheim Animal Health Usa Inc |
Compuestos heterociclicos como anthelminticos.
|
CN113135913B
(zh)
*
|
2021-04-28 |
2022-05-24 |
沈阳药科大学 |
3-取代基-6-吡啶类取代基-六元并五元杂环类衍生物及其制法与用途
|
AR127495A1
(es)
|
2021-11-01 |
2024-01-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Compuestos de pirrolopiridazina como antihelmínticos
|